A patient-derived blood-brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer's disease
Joanna Marta Wasielewska, Kathryn Szostak, Lachlan E. McInnes, Hazel Quek, Juliana C.S. Chaves, Jeffrey R. Liddell, Jari Koıstınaho, Lotta E. Oikari, Paul S. Donnelly, Anthony Robert White
This paper develops a patient-derived BBB model to screen copper bis(thiosemicarbazone) complexes for Alzheimer's disease treatment, identifying CuII(dtsm) as a promising candidate with improved BBB permeability and anti-inflammatory effects.
ACS Chemical Neuroscience · Mar 13, 2024Peer-reviewedNeuroscience